TriaGen Wealth Management LLC Invests $4.55 Million in Edwards Lifesciences Corporation $EW

TriaGen Wealth Management LLC has acquired a new position of 53,398 shares in Edwards Lifesciences (NYSE:EW) during the fourth quarter, an investment valued at approximately $4.55 million, making it their 13th largest holding. The medical research company has a “Moderate Buy” consensus rating from analysts, with a target price of $95.74, despite recently missing Q4 EPS estimates. Institutional investors hold nearly 79.5% of the company’s stock, though recent insider selling has also been noted.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin